Stuttgart - Delayed Quote EUR

Blueprint Medicines Corp (2L9.SG)

Compare
107.90
-0.60
(-0.55%)
At close: January 31 at 9:34:02 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,049,250.00
1,349,902.00
1,252,225.00
1,718,393.00
Total Liabilities Net Minority Interest
918,641.00
835,225.00
281,490.00
248,305.00
Total Equity Gross Minority Interest
130,609.00
514,677.00
970,735.00
1,470,088.00
Total Capitalization
339,144.00
636,909.00
970,735.00
1,470,088.00
Common Stock Equity
130,609.00
514,677.00
970,735.00
1,470,088.00
Capital Lease Obligations
93,684.00
103,368.00
111,408.00
89,604.00
Net Tangible Assets
130,609.00
514,677.00
970,735.00
1,470,088.00
Working Capital
593,470.00
863,417.00
404,260.00
796,957.00
Invested Capital
369,422.00
653,760.00
970,735.00
1,470,088.00
Tangible Book Value
130,609.00
514,677.00
970,735.00
1,470,088.00
Total Debt
332,497.00
242,451.00
111,408.00
89,604.00
Net Debt
167,527.00
19,374.00
--
--
Share Issued
61,147.24
59,958.92
59,141.09
57,793.53
Ordinary Shares Number
61,147.24
59,958.92
59,141.09
57,793.53
12/31/2020 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers